Published Year: 2020
Global Human Microbiome Sequencing Market: Focus on Products, Technologies, Applications, End Users,
The Global Human Microbiome Sequencing Market Report by BIS Research projects the market to...
A quick peek into the report
Report Description
Market Report Coverage - Skin Microbiome Modulators
Forecast Period: 2020-2030
CAGR During Forecast Period: 16.90%
Key Questions Answered in this Report:
What are the key takeaways from the highly dynamic funding scenario in the skin microbiome modulators market?
Market Overview
The global skin microbiome modulators market was valued at $541.1 million in 2019 and is anticipated to grow over $2,971.6 million
Table of Contents
1.1 Inclusion and Exclusion
2.1 Scope of Work
2.2 Key Questions Answered in the Report
3.1 Global Skin Microbiome Modulators Market: Research Methodology
3.2 Primary Data Sources
3.3 Secondary Data Sources
3.4 Market Estimation Model
3.5 Criteria for Company Profiling
7.1 Synergistic Activities
7.2 Business Expansion Activities and Others
7.3 Product Launches and Product Updates
7.4 Mergers and Acquisitions
7.5 Market Share Analysis, 2018-2019
7.6 Growth Share Analysis
7.6.1 Growth Share Analysis (by Company)
7.6.2 Growth Share Analysis (by Application)
7.6.3 Growth Share Analysis (by Country)
7.7 Pipeline Analysis (2017-2019)
4.1 Market Definition
4.2 The Human Microbiome Project: 2007-2016
4.3 Market Size and Growth Potential, $Million, 2019-2030
4.4 Future Potential
4.5 COVID-19 Impact on the Global Skin Microbiome Modulators Market
5.1 Overview
5.2 Legal Requirements and Framework in the U.S.
5.3 Legal Requirements and Framework in Europe
5.4 Legal Requirements and Framework in Asia-Pacific
5.4.1 China
5.5 Funding Scenario
5.6 Patent Analysis
5.6.1 Overview
5.6.2 Patent Classification
5.6.3 Regional Analysis
5.6.4 Microorganism Analysis
5.6.5 Key Highlights
5.7 Global Microbiome Consortiums
6.1 Overview
6.2 Impact Analysis
6.3 Market Drivers
6.3.1 Increasing Emphasis on Microbiome’s Potential for Human Health
6.3.2 Increasing Entry of Legacy Cosmetic Companies into Skin Microbiome Modulators Industry
6.3.3 Decreasing Cost of Sequencing
6.4 Market Restrains
6.4.1 Non-Standardization of Claims and Stringent Regulatory Standards
6.4.2 Lack of Knowledge on Probiotic-Based Products
6.4.3 Cost of the Cosmetic Products-Based on Probiotics
6.5 Market Opportunities
6.5.1 Investiture of Next-Generation Probiotics for Enhancement of Probiotic Drugs
6.5.2 Growing Integrative Industry-Academia Collaboration
6.5.3 Pipeline Drugs Anticipated Future Potential to the Skin Microbiome Modulators Market
8.1 Overview
8.2 Probiotics
8.3 Prebiotics
8.4 Drugs
9.1 Overview
9.2 Skin Care
9.3 Hair Care
9.4 Other Applications
10.1 Overview
10.2 Online Channels
10.3 Hypermarkets and Supermarkets
10.4 Direct Selling
10.5 Specialty Store
10.6 Drug Stores
11.1 Overview
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 France
11.3.3 U.K.
11.3.4 Italy
11.3.5 Spain
11.3.6 Rest-of-Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 South Korea
11.4.3 Australia
11.4.4 India
11.4.5 Rest-of-APAC
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest-of-Latin America
11.6 Rest-of-the-World
12.1 Overview
12.2 AOBiome
12.2.1 Company Overview
12.2.2 Role of AOBiome in the Global Skin Microbiome Modulators Market
12.2.3 SWOT Analysis
12.3 Azitra, Inc.
12.3.1 Company Overview
12.3.2 Role of Azitra, Inc. in the in the Global Skin Microbiome Modulators Market
12.3.3 SWOT Analysis
12.4 Colgate-Palmolive Company
12.4.1 Company Overview
12.4.2 Role of Colgate-Palmolive in the Global Skin Microbiome Modulators Market
12.4.3 Financials
12.4.4 SWOT Analysis
12.5 Evelo Biosciences, Inc.
12.5.1 Company Overview
12.5.2 Role of Evelo Biosciences, Inc. in the Global Skin Microbiome Modulators Market
12.5.3 SWOT Analysis
12.6 GALLINÉE
12.6.1 Company Overview
12.6.2 Role of GALLINÉE in the Global Skin Microbiome Modulators Market
12.6.3 SWOT Analysis
12.7 Glowbiotics, Inc.
12.7.1 Company Overview
12.7.2 Role of Glowbiotics, Inc. in the Global Skin Microbiome Modulators Market
12.7.3 SWOT Analysis
12.8 Johnson & Johnson Services, Inc.
12.8.1 Company Overview
12.8.2 Role of Johnson & Johnson in the Global Skin Microbiome Modulators Market
12.8.3 Financials
12.8.4 Key Insights about Financial Health of the Company
12.8.5 SWOT Analysis
12.9 L’Oréal S.A.
12.9.1 Company Overview
12.9.2 Role of L’Oréal S.A in the Global Skin Microbiome Modulators Market
12.9.3 Financials
12.9.4 SWOT Analysis
12.10 MATRISYS BIOSCIENCE
12.10.1 Company Overview
12.10.2 Role of MATRISYS BIOSCINCE in the Global Skin Microbiome Modulators Market
12.10.3 SWOT Analysis
12.11 Quorum Innovations
12.11.1 Company Overview
12.11.2 Role of Quorum Innovations in the Global Skin Microbiome Modulators Market
12.11.3 SWOT Analysis
12.12 Revlon
12.12.1 Role of Revlon in the Global Skin Microbiome Modulators Market
12.12.2 Financials
12.12.3 Key Insights About Financial Health of the Company
12.12.4 SWOT Analysis
12.13 Siolta Therapeutics
12.13.1 Company Overview
12.13.2 Role of Siolta Therapeutics in the Global Skin Microbiome Modulators Market
12.13.3 SWOT Analysis
12.14 The Estée Lauder Companies Inc.
12.14.1 Company Overview
12.14.2 Role of The Estee Lauder Companies, Inc. in the Global Skin Microbiome Modulators Market
12.14.3 SWOT Analysis
12.15 TULA Life, INC
12.15.1 Company Overview
12.15.2 Role of TULA Life, INC in the Global Skin Microbiome Modulators Market
12.15.3 SWOT Analysis
12.16 Unilever
12.16.1 Company Overview
12.16.2 Role of Unilever in the Global Skin Microbiome Modulators Market
12.16.3 Financials
12.16.4 SWOT Analysis
12.17 Yakult Honsha Co., Ltd
12.17.1 Company Overview
12.17.2 Role of Yakult Honsha Co., Ltd. in the Global Skin Microbiome Modulators Market
12.17.3 Financials
12.17.4 SWOT Analysis
Table 5.1: Global Microbiome Consortiums and Their Participants
Table 6.1: Pipeline Drugs in the Skin Microbiome Modulators Market
Table 8.1: Examples of Probiotics in the Global Skin Microbiome Modulators Market
Table 8.2: Examples of Prebiotics in Global Skin Microbiome Modulators Market
Figure 1: Impact Analysis of Market Drivers and Market Challenges on the Global Skin Microbiome Modulators Market
Figure 2: Global Skin Microbiome Modulators Market (by Product), 2019 vs. 2030 ($Million)
Figure 3: Global Skin Microbiome Modulators Market (by Application), 2019 vs. 2030 ($Million)
Figure 4: Global Skin Microbiome Modulators Market (by Distribution Channel), 2019 vs. 2030 ($Million)
Figure 5: Global Skin Microbiome Modulators Market Snapshot
Figure 2.1: Global Skin Microbiome Modulators Market Segmentation
Figure 3.1: Global Skin Microbiome Modulators Market Research Methodology
Figure 3.2: Primary Research Methodology
Figure 3.3: Bottom-Up Approach (Segment-Wise Analysis)
Figure 3.4: Top-Down Approach (Segment-Wise Analysis)
Figure 4.1: Human Microbiota Sites
Figure 4.2: Significant Milestones from the Human Microbiome Project (Phase 1)
Figure 4.3: Global Skin Microbiome Modulators Market, 2019-2030
Figure 4.4: Global Skin Microbiome Modulators Market: COVID-19 Impact
Figure 5.1: Funding in Microbiome Projects (FY2012-FY2016)
Figure 5.2: Specific Microbial Members/Microbial Products Investigated in Microbiome Projects
Figure 6.1: Impact Analysis
Figure 6.2: Annual NIH Funding in the Human Microbiome Research, FY2007-FY2016
Figure 6.3: Decreasing Cost and Increasing Output (TB) of Genome Sequencing (2009-2025)
Figure 7.1: Share of Key Developments and Strategies, January 2017-June 2020
Figure 7.2: Synergistic Activities Share (by Company), January 2017-February 2020
Figure 7.3: Business Expansion Activities Share (by Company), January 2017- June 2020
Figure 7.4: Number of Product Launches (by Company), January 2017-June 2020
Figure 7.5: Market Share Analysis for Global Skin Microbiome Modulators Market, 2018 and 2019
Figure 7.6: Growth Share Analysis for Global Skin Microbiome Modulators Market (by Company), 2019
Figure 7.7: Growth Share Analysis for Global Skin Microbiome Modulators Market (by Application), 2019-2030
Figure 7.8: Growth Share Analysis for Global Skin Microbiome Modulators Market (by Country), 2019-2030
Figure 8.1: Global Skin Microbiome Modulators Market (by Product Type)
Figure 8.2: Global Skin Microbiome Modulators Market (by Product Type), 2019 and 2030
Figure 8.3: Global Skin Microbiome Modulators Market (by Probiotics), 2019-2030
Figure 8.4: Global Skin Microbiome Modulators Market (by Probiotic Microbes), 2019 and 2030
Figure 8.5: Global Skin Microbiome Modulators Market (by Bacterial Probiotics), 2019 and 2030
Figure 8.6: Global Skin Microbiome Modulators Market (by Prebiotics), 2019-2030
Figure 8.7: Global Skin Microbiome Modulators Market (by Drugs), 2019-2030
Figure 9.1: Global Skin Microbiome Modulators Market (by Application)
Figure 9.2: Global Skin Microbiome Modulators Market (by Application), 2019-2030
Figure 9.3: Global Skin Microbiome Modulators Market (by Skin Care), 2019-2030
Figure 9.4: Global Skin Microbiome Modulators Market (by Skin Care Applications), 2019 and 2030
Figure 9.5: Global Skin Microbiome Modulators Market (by Skin Care), 2019-2030
Figure 9.6: Global Skin Microbiome Modulators Market (by Skin Care), 2019-2030
Figure 10.1: Global Skin Microbiome Modulators Market (by Distribution Channels)
Figure 10.2: Global Skin Microbiome Modulators Market (by Online Channels), 2019-2030
Figure 10.3: Global Skin Microbiome Modulators Market (by Hypermarkets and Supermarkets), 2019-2030
Figure 10.4: Global Skin Microbiome Modulators Market (by Direct Selling), 2019-2030
Figure 10.5: Global Skin Microbiome Modulators Market (by Specialty Store), 2019-2030
Figure 10.6: Global Skin Microbiome Modulators Market (by Drug Stores), 2019-2030
Figure 11.1: Global Skin Microbiome Modulators Market (by Region), 2019 and 2030
Figure 11.2: Global Skin Microbiome Modulators Market (by Region), 2019-2030
Figure 11.3: Global Skin Microbiome Modulators Market Share (by Region), 2019
Figure 11.4: Global Skin Microbiome Modulators Market Share (by Region), 2030
Figure 11.5: North America Skin Microbiome Modulators Market, 2019-2030
Figure 11.6: North America: Market Dynamics
Figure 11.7: North America Skin Microbiome Modulators Market (by Country), 2019-2030
Figure 11.8: U.S. Skin Microbiome Modulators Market, 2019-2030
Figure 11.9: Canada Skin Microbiome Modulators Market, 2019-2030
Figure 11.10: Europe Skin Microbiome Modulators Market, 2019-2030
Figure 11.11: Europe: Market Dynamics
Figure 11.12: Europe Skin Microbiome Modulators Market (by Country), 2019-2030
Figure 11.13: Germany Skin Microbiome Modulators Market, 2019-2030
Figure 11.14: France Skin Microbiome Modulators Market, 2019-2030
Figure 11.15: U.K. Skin Microbiome Modulator Market, 2019-2030
Figure 11.16: Italy Skin Microbiome Modulators Market, 2019-2030
Figure 11.17: Spain Skin Microbiome Modulators Market, 2019-2030
Figure 11.18: Rest-of-Europe Skin Microbiome Modulators Market, 2019-2030
Figure 11.19: Asia-Pacific Skin Microbiome Modulators Market, 2019-2030
Figure 11.20: APAC: Market Dynamics
Figure 11.21: APAC Sin Microbiome Modulators Market (by Country), 2019-2030
Figure 11.22: Japan Skin Microbiome Modulators Market, 2019-2030
Figure 11.23: China Skin Microbiome Modulators Market, 2019-2030
Figure 11.24: South Korea Skin Microbiome Modulators Market, 2019-2030
Figure 11.25: Australia Skin Microbiome Modulators Market, 2019-2030
Figure 11.26: India Skin Microbiome Modulators Market, 2019-2030
Figure 11.27: RoAPAC Skin Microbiome Modulators Market, 2019-2030
Figure 11.28: Latin America Skin Microbiome Modulators Market, 2019-2030
Figure 11.29: Latin America: Market Dynamics
Figure 11.30: Latin America Skin Microbiome Modulators Market (by Country), 2019-2030
Figure 11.31: Brazil Skin Microbiome Modulators Market, 2019-2030
Figure 11.32: Mexico Skin Microbiome Modulators Market, 2019-2030
Figure 11.33: Rest-of-Latin America Skin Microbiome Modulators Market, 2019-2030
Figure 11.34: RoW Skin Microbiome Modulators Market, 2019-2030
Figure 12.1: Total Number of Companies Profiled
Figure 12.2: AOBiome (Mother Dirt): Product Portfolio
Figure 12.3: AOBiome: Pipeline Products (Drugs)
Figure 12.4: AOBiome: SWOT Analysis
Figure 12.5: Azitra, Inc.: Pipeline Products
Figure 12.6: Azitra, Inc.: SWOT Analysis
Figure 12.7: Colgate-Palmolive Company (Tom’s of Maine): Product Offerings
Figure 12.8. Colgate-Palmolive Company: Overall Financials, 2017-2019
Figure 12.9: Colgate-Palmolive Company: Revenue (by Segment), 2017-2019
Figure 12.10: Colgate-Palmolive Company.: SWOT Analysis
Figure 12.11: Evelo Biosciences, Inc.: Pipeline Products
Figure 12.12: Evelo Biosciences, Inc.: SWOT Analysis
Figure 12.13: GALLINÉE: Product Portfolio
Figure 12.14: GALLINEE.: SWOT Analysis
Figure 12.15: Glowbiotics, Inc.: Product Portfolio
Figure 12.16: Glowbiotics, Inc.: SWOT Analysis
Figure 12.17: Johnson and Jonson Services, Inc. (Aveeno): Product Portfolio
Figure 12.18: Johnson & Johnson Services, Inc. Company: Overall Financials, 2017-2019
Figure 12.19: Johnson & Johnson Services, Inc. Company: R&D Expenditure, 2017-2019
Figure 12.20: Johnson & Johnson Services, Inc.: SWOT Analysis
Figure 12.21: L’Oréal S.A.: Product Portfolio
Figure 12.22: L’Oréal S.A Company: Overall Financials, 2017-2019
Figure 12.23: L’Oreal S.A.: SWOT Analysis
Figure 12.24: MATRISYS BIOSCIENCE: Pipeline Products Portfolio
Figure 12.25: MATRISYS BIOSCIENCE: SWOT Analysis
Figure 12.26: Quorum Innovations: Pipeline Product Portfolio
Figure 12.27: Quorum Innovations: SWOT Analysis
Figure 12.28: Revlon (Elizabeth Arden, Inc.): Product Portfolio
Figure 12.29: Revlon: Overall Financials, 2017-2019
Figure 12.30: Revlon: Revenue (by Segment), 2017-2019
Figure 12.31: Revlon (Elizabeth Arden): Revenue (by Region), 2017-2019
Figure 12.32: Revlon: R&D Expenditure, 2017-2019
Figure 12.33: Revlon: SWOT Analysis
Figure 12.34: Siolta Therapeutics: Product Offerings
Figure 12.35: Siolta Therapeutics: SWOT Analysis
Figure 12.36: The Estee Lauder Companies, Inc.: Overall Product Portfolio
Figure 12.37: The Estee Lauder Companies Inc.: SWOT Analysis
Figure 12.38: TULA Life, INC: Product Portfolio
Figure 12.39: TULA Life, INC: SWOT Analysis
Figure 12.40: Unilever: Product Portfolio
Figure 12.41: Unilever: Overall Financials, 2017-2019
Figure 12.42: Unilever: Revenue (by Segment), 2017-2019
Figure 12.43: Unilever: SWOT Analysis
Figure 12.44: Yakult Honsha Co., Ltd.: Product Portfolio
Figure 12.45: Yakult Honsha Co., Ltd: Overall Financials, 2017-2019
Figure 12.46: Yakult Honsha Co., Ltd: Revenue (by Segment), 2017-2019
Figure 12.47: Yakult Honsha Co., Ltd.: SWOT Analysis
Report Description
|
Market Report Coverage - Skin Microbiome Modulators |
|||
|
Base Year |
2019 |
Market Size in 2019 |
$541.1 Million |
|
Forecast Period |
2020-2030 |
Value Projection and Estimation by 2030 |
$2,971.6 Million |
|
CAGR During Forecast Period |
16.90% |
Number of Tables |
4 |
|
Number of Pages |
200 |
Number of Figures |
127 |
|
Research Hours |
|
|
|
|
Market Segmentation |
• By Product Type: Probiotics, Prebiotics, and Drugs • By Application: Skin Care, Hair Care, and Other Applications • By Distribution Channels: Online Channels, Hypermarkets and Supermarkets, Direct Selling, Specialty Stores, Drug Stores • By Region: North America, Europe, Asia-Pacific, Latin America, and Rest-of-the-World |
||
|
Regional Segmentation |
• North America: U.S. and Canada • Europe: Germany, France, U.K., Italy, Spain, and Rest-of-Europe • Asia-Pacific: Japan, China, India, South Korea, Australia, and Rest-of-Asia-Pacific • Latin America: Brazil, Mexico, and Rest-of-Latin America • Rest-of-the-World |
||
|
Growth Drivers |
• Increasing Emphasis on Microbiome’s Potential for Human Health • Increasing Entry of Legacy Cosmetic Companies into Skin Microbiome Modulators Industry • Decreasing Cost of Sequencing |
||
|
Market Challenges |
• Non-Standardization of Claims and Stringent Regulatory Standards • Lack of Knowledge on Probiotic-based Products • Cost of the Cosmetic Products-based on Probiotics |
||
|
Market Opportunities |
• Investiture of Next Generation Probiotics for Enhancement of Probiotic Drugs • Growing Integrative Industry-Academia Collaboration • Pipeline Drugs Anticipated Future Potential to The Skin Microbiome Modulators Market |
||
|
Key Companies Profiled |
AOBiome, Azitra, Inc., Colgate-Palmolive Company, Evelo Biosciences Inc., GALLINEE , Glowbiotics,Inc., Johnson & Johnson Services, Inc., L’Oréal S.A.,MATRYSIS BIOSCIENCE, Quorum Innovations, Revlon, Siolta Therapeutics, The Estee Lauder Companies , Inc., TULA Life Inc., Unilever , and Yakult Honsha Co. Ltd. |
||
Key Questions Answered in this Report:
• What are the major market drivers, challenges, and opportunities, and their respective impacts in the global skin microbiome modulators market?
• What are the key development strategies which are implemented by the major players in order to sustain in the competitive market?
• What are the key regulatory hurdles while defining products as cosmetics or food or therapeutics being faced by the industry players?
• What are the key takeaways from the highly dynamic funding scenario in the skin microbiome modulators market?
• What are the key microorganism formulations being patented for emerging application areas?
• Which is the dominant product type developed by the leading and emerging players for the global skin microbiome modulators market?
• What are the key probiotic strains being employed for product formulation in the skin microbiome modulators market?
• How will the commercialization of drugs or medical probiotics impact the market scenario?
• What are the key technologies that have been used by leading players in the global skin microbiome modulators market?
• How each segment of the market is expected to grow during the forecast period from 2020 to 2030 based on:
o product type
o application
o distribution channel
o region
• Which companies are anticipated to be highly disruptive in the future, and why?
• What are the key application areas for skin microbiome modulators in 2020, and which application areas are expected to witness growth in the forecast period?
Market Overview
The skin microbiome has been an exciting area of research, significantly expanding applications beyond the gut microbiome. The use of probiotics in skin creams has been an area of research for over a decade now. As further understanding enables comprehension of the function of the skin microbiome and how it can be modulated to address diseases, such as acne, eczema, and rosacea, the global cosmetics industry is investing tremendously in the space. In addition, the landscape is also teeming with a large number of start-ups that have already entered the market with commercialized products. However, a major revelation would definitely come in the form of drugs that are currently being developed based on modulating the skin microbiome.
The current skin microbiome modulators market is mainly dominated by several cosmetic majors, such as Colgate-Palmolive Company, Johnson & Johnson Services, Inc., L’Oréal S.A., TULA Life Inc., Unilever, and Yakult Honsha Co. Ltd. which offer a wide variety of probiotics and prebiotics products for skin care and hair care applications.
The existing market of skin microbiome modulators is favored by multiple factors, which include a global emphasis on the microbiome’s potential for human health. In addition, entry of legacy cosmetic companies into the skin microbiome modulators industry to the global skin microbiome modulators market will provide a lucrative growth for this market.
Within the research report, the market is segmented on the basis of product type, application, distribution channels, and region, which highlight value propositions and business models useful for industry leaders and stakeholders. The research also comprises country-level analysis, go-to-market strategies of leading players, future opportunities, among others, to detail the scope and provide 360-degree coverage of the domain.
Competitive Landscape
Major players, Colgate-Palmolive Company, Johnson & Johnson Services, Inc., L’Oréal S.A., TULA Life Inc., Unilever, and Yakult Honsha Co. Ltd. including among others, led the number of key developments witnessed by the market. On the basis of region, North America is expected to retain a leading position throughout the forecast period 2020-2030, followed by Europe. This is a result of the presence of leading industry players in this region, coupled up with the millennial population growth.
You may also like
Published Year: 2019
Global Human Microbiome Therapeutics Market: Focus on Drugs, Pipeline Analysis, Funding Scenario, Th
Human Microbiome Therapeutics Industry Analysis by BIS Research projects the market to grow at...
Published Year: 2018
Global Human Microbiome Modulators Market – Analysis and Forecast, 2018-2023: Focus on Non-Dairy S
The global human microbiome modulators market has been witnessing a steady annual growth rate...
Global Skin Microbiome Modulators Market
Focus on Products, Applications, Distribution Channels, Country Data (14 Countries), and Competitive Landscape - Analysis and Forecast, 2019-2030